What is Impilo?
Founded in 2020, Impilo provides a robust API infrastructure solution designed to automate the procurement, distribution, and integration of digital health devices. In an era where remote patient monitoring and decentralized care models are becoming standard, the company addresses the significant friction associated with device supply chain management. By offering a unified platform that supports the entire lifecycle of health hardware, Impilo enables healthcare organizations to scale their digital initiatives without the burden of fragmented vendor relationships or manual fulfillment processes. The company's market position is defined by its ability to bridge the gap between hardware manufacturers and clinical delivery systems, effectively serving as the connective tissue for the digital health ecosystem.
How much funding has Impilo raised?
Impilo has raised a total of $11.5M across 1 funding round:
Series A
$11.5M
Series A (2024): $11.5M with participation from Construct Capital, GC 1 Capital, and One Way Ventures
Key Investors in Impilo
Construct Capital
Construct Capital is a firm focused on operational excellence and specialized service delivery, bringing a disciplined approach to its investment portfolio.
One Way Ventures
One Way Ventures is a venture capital firm dedicated to supporting immigrant founders in building high-impact, global technology companies.
GC 1 Capital
Undisclosed investor participating in the funding round.
What's next for Impilo?
With this major enterprise-level funding, Impilo is expected to prioritize the expansion of its API capabilities and the deepening of its integration network. The capital will likely be deployed to enhance the platform's automation features, allowing for more seamless interoperability between diverse health devices and electronic health record systems. As the demand for integrated digital health solutions continues to rise, Impilo's strategic focus will likely shift toward capturing a larger share of the enterprise healthcare market, solidifying its role as an essential infrastructure provider for health systems and digital health startups alike. The company remains well-positioned to capitalize on the ongoing shift toward data-driven, device-enabled patient care.
See full Impilo company page
